This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Treatment

Authoring team

Half of patients with periodic ataxia will respond to acetazolamide. MRI spectroscopy suggests that the defect in these patients may be a failure to regulate intracellular pH in the cerebellum.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page